Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?

× No keyword cloud information.

80 in total

1. Beta-blockers and asthma.

Authors: P B Decalmer; S S Chatterjee; J M Cruickshank; M K Benson; G M Sterling
Journal: Br Heart J Date: 1978-02

Review 2. The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.

Authors: B N Prichard; R J Walden
Journal: Br J Clin Pharmacol Date: 1982 Impact factor: 4.335

3. Influence of xamoterol, a partial beta 1-selective agonist, on physical performance capacity and cardiocirculatory, metabolic and hormonal parameters.

Authors: T Kullmer; W Kindermann; A Urhausen; M Hess
Journal: Eur J Clin Pharmacol Date: 1988 Impact factor: 2.953

4. The first dose hemodynamic responses to Visacor (ICI 141-292) in essential hypertension.

Authors: P Lund-Johansen; P Omvik; H Haugland
Journal: Acta Med Scand Suppl Date: 1985

5. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

Authors: M R Bristow; R Ginsburg; V Umans; M Fowler; W Minobe; R Rasmussen; P Zera; R Menlove; P Shah; S Jamieson
Journal: Circ Res Date: 1986-09 Impact factor: 17.367

6. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade.

Authors: K Swedberg; A Hjalmarson; F Waagstein; I Wallentin
Journal: Lancet Date: 1979-06-30 Impact factor: 79.321

Review 7. Clinical consequences of abrupt drug withdrawal.

Authors: C F George; D Robertson
Journal: Med Toxicol Adverse Drug Exp Date: 1987 Sep-Oct

8. Cardioselectivity, kinetics, hemodynamics, and metabolic effects of xamoterol.

Authors: G Jennings; A Bobik; C Oddie; R Restall
Journal: Clin Pharmacol Ther Date: 1984-05 Impact factor: 6.875

9. Studies on the mechanism of the acute antihypertensive and vasodilator actions of several beta-adrenoceptor antagonists.

Authors: E J Sybertz; T Baum; K K Pula; S Nelson; E Eynon; C Sabin
Journal: J Cardiovasc Pharmacol Date: 1982 Sep-Oct Impact factor: 3.105

10. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.

Authors: P M McCaffrey; J G Riddell; R G Shanks
Journal: Br J Clin Pharmacol Date: 1987-11 Impact factor: 4.335

11 in total

1. Selectivity of antagonist and partial agonist activity of celiprolol in normal subjects.

Authors: N M Wheeldon; D G McDevitt; B J Lipworth
Journal: Br J Clin Pharmacol Date: 1992-10 Impact factor: 4.335

2. Differential cardiovascular effects of propranolol, atenolol, and pindolol measured by impedance cardiography.

Authors: S H Thomas; R C Cooper; M Ekwuru; S Fletcher; J Gilbody; T S Husseyin; M Ishaque; R Jagathesan; G Reddy; S E Smith
Journal: Eur J Clin Pharmacol Date: 1992 Impact factor: 2.953

3. Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.

Authors: A Grove; B J Lipworth
Journal: Thorax Date: 1996-06 Impact factor: 9.139

Review 4. The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomes.

Authors: J D Fitzgerald
Journal: Cardiovasc Drugs Ther Date: 1991-06 Impact factor: 3.727

5. Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.

Authors: A Grove; B J Lipworth
Journal: Thorax Date: 1996-01 Impact factor: 9.139

Review 6. Clinical pharmacology through the looking glass: reflections on the racemate vs enantiomer debate.

Authors: M S Lennard
Journal: Br J Clin Pharmacol Date: 1991-06 Impact factor: 4.335

7. Cardiac beta 2-adrenoceptors and the inotropic response to exercise in man.

Authors: C Nyarko-Adomfeh
Journal: Clin Auton Res Date: 1991-12 Impact factor: 4.435

8. The effects of selective beta-adrenoceptor antagonists and partial agonist activity on renal function during exercise in normal subjects and those with moderate renal impairment.

Authors: D Taverner; I G Mackay; K Craig; M L Watson
Journal: Br J Clin Pharmacol Date: 1991-09 Impact factor: 4.335

9. Expression of the beta 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone.

Authors: A Grove; L C McFarlane; B J Lipworth
Journal: Thorax Date: 1995-02 Impact factor: 9.139

10. Effects of dilevalol (R,R-labetalol) compared with nifedipine on heart rate, blood pressure and muscle blood flow at rest and on exercise in hypertensive patients.

Authors: T Walley; Y Tsao; A Scott; E Mackay; M Vandenburg; A Breckenridge
Journal: Br J Clin Pharmacol Date: 1993-06 Impact factor: 4.335